20744-51-8,
Antibiotic NK 1012-2,
Deoxystreptamine-kanosaminide,
BRN 0026899,
NK-1012-2,
Streptamine, 4-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy-, L-,
AC1L4NLP,
Tobramycin rings B and C,
AC1Q55IV,
(1s,2s,3r,4s,6r)-4,6-diamino-2,3-dihydroxycyclohexyl 3-amino-3-deoxy-|A-d-glucopyranoside,
Kanamycin A Related Compound 2,
C12H25N3O7,
ZINC5426353,
D-Streptamine, 6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy-,
D-Streptamine, 6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy- (9CI),
LS-146920,
Z1881,
6-o-(3-Amino-3-deoxy-alpha-D-deoxyglucopyranosyl)-2-deoxy-streptamine,
(2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol,
(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol,
TOBRAMYCINA,
KST-1A5623,
AR-1A1526,
CID209916,
C12-H25-N3-O7,
4-18-00-07631 (Beilstein Handbook Reference),
5410-42-4,